Blood test may guide cancer care: COPE trial launches

NCT ID NCT04258137

Recruiting now Knowledge-focused Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times

Summary

This study is for people with advanced colorectal or non-small cell lung cancer. It tests whether adding a special blood test (ctDNA) to regular scans helps doctors choose the best treatment. About 332 participants will be randomly assigned to either standard care or the extra blood test. The goal is to see if the blood test improves survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

CHRU Brest
RECRUITING

Brest, 29200, France

Contact Email: •••••@•••••

Contact
Centre hospitalier de la Côte Basque
RECRUITING

Bayonne, 64109, France

Contact Email: •••••@•••••

Contact
Clinique Tivoli-Ducos
RECRUITING

Bordeaux, 33000, France

Contact Email: •••••@•••••

Contact
Institut Bergonie
RECRUITING

Bordeaux, 33076, France

Contact Email: •••••@•••••

Contact
Polyclinique Bordeaux Nord Aquitaine
RECRUITING

Bordeaux, 33077, France

Contact Email: •••••@•••••

Contact
Polyclinique Marzet
RECRUITING

Pau, 64000, France

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER